Scope

Aims and Scope: 

Microbial Bioactives aims to publish in-depth articles exploring biologically active compounds from microorganisms and microbe-targeting therapeutics, with relevance to multidisciplinary applications, pharmacological benefits, and pharmaceutical contexts. By doing so, the journal aims to effectively share pertinent scientific insights and impactful discoveries with researchers, scholars, medical practitioners, and industries. The primary goal of the journal is to establish an interactive platform that fosters the exploration and transformation of diverse bioactive entities into essential and valuable products, spanning biopharmaceuticals, bio-agricultural inputs, biocontrol agents, biocatalysts, health supplements, and more. Microbial Bioactives seeks to publish comprehensive articles that delve into the realm of biologically active compounds derived from microorganisms or designed to target microbes. By doing so, the journal aims to effectively share pertinent scientific insights and impactful discoveries with researchers, scholars, medical practitioners, and industries. The primary goal of the journal is to establish an interactive platform that fosters the exploration and transformation of diverse bioactive entities into essential and valuable products, spanning biopharmaceuticals, bio-agricultural inputs, biocontrol agents, biocatalysts, health supplements, and more.

The journal enthusiastically welcomes a variety of contributions including full-length articles presenting original research, thought-provoking reviews, informative data reports, insightful letters to the editor, concise short communications, and in-depth technical/methodological reports. A key focus of the journal is to expedite the advancement of scientific knowledge by highlighting the novelty of research findings, thereby avoiding redundancy or repetition.

Manuscripts submitted to the journal can be oriented towards either bioactive compounds originating from microorganisms (such as proteins, lipoproteins, phospholipids, secondary metabolites, antimicrobial peptides, functional molecules within pre- and probiotics, bacteriocins, immunogenic molecules, enzymes, fengycin, and molecules exhibiting anti-cancer, anti-tumor, anti-inflammatory, immune regulatory, and antioxidant activities) or manuscripts that are designed to target microorganisms. The latter category encompasses a range of subjects that align with the following areas of interest.

Microbial Bioactives also assists authors in complying with the NIH Public Access Policy, enabling their work to reach a wider audience. For more comprehensive guidelines and information, please refer to the detailed Guide for Authors.

The bioactive compounds oriented manuscripts either of microbial origin (e.g. proteins, lipoproteins, phospholipids, secondary metabolites, antimicrobial peptides, functional molecules in pre- and probiotics, bacteriocins, immunogenic molecules, enzymes, fengycin, molecules exerting anti-cancer, anti-tumor, anti-inflammatory, immune regulatory and anti-oxidant activities, etc) ) or microbe directed oriented manuscripts focusing the following area are appreciated and welcomed.

• Discovery of novel Bioactive compounds

• Screening of potential microbes from different ecosystem 

• Bioactives from marine microbiota

• Purification and molecular structure elucidation

• Omics based analysis

• Heterologous expression and bio-efficacy study

• Production scaling up by bioprocess technology 

• Applications in different biological systems

• Mechanisms of action: Physiological effects

• Mechanisms of susceptibility and resistance

• Mechanism and demonstration of bio-catalysis and bioconversion 

• Experimental therapeutics and approaches of administration

• Preclinical studies and clinical trials

• Establishment as clinical therapeutics

• Pharmacological characterization

• Influence in public health